50 related articles for article (PubMed ID: 36123851)
41. Clear cell carcinoma of the ovary: Clues for radiologists to perform a correct diagnosis.
Rodrigues S; Braga M; Félix A; Cunha TM
Curr Probl Diagn Radiol; 2024; 53(2):271-279. PubMed ID: 37925237
[TBL] [Abstract][Full Text] [Related]
42. Advanced primary vaginal squamous cell carcinoma: A case report and literature review.
Shen Y; Meng X; Wang L; Wang X; Chang H
Front Immunol; 2022; 13():1007462. PubMed ID: 36483563
[TBL] [Abstract][Full Text] [Related]
43. Ovarian teratoid carcinosarcoma with a
Aoki M; Takaya H; Otani T; Nakai H; Murakami K; Matsumura N
Int Cancer Conf J; 2022 Oct; 11(4):231-237. PubMed ID: 36186232
[TBL] [Abstract][Full Text] [Related]
44. Ovarian clear cell cancer associated with Trousseau syndrome: A case report and literature review.
You Y; Chen X; Jiang Y; Cheng W
Medicine (Baltimore); 2022 Nov; 101(47):e32106. PubMed ID: 36451485
[TBL] [Abstract][Full Text] [Related]
45. Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics.
Tong A; Di X; Zhao X; Liang X
Front Genet; 2023; 14():952379. PubMed ID: 36873929
[TBL] [Abstract][Full Text] [Related]
46. Clinical analysis and literature review of a case of ovarian clear cell carcinoma with PIK3CA gene mutation: A case report.
Farah AM; Gu S; Jia Y
Medicine (Baltimore); 2022 Sep; 101(37):e30666. PubMed ID: 36123851
[TBL] [Abstract][Full Text] [Related]
47. Precision medicine for ovarian clear cell carcinoma based on gene alterations.
Kuroda T; Kohno T
Int J Clin Oncol; 2020 Mar; 25(3):419-424. PubMed ID: 32020380
[TBL] [Abstract][Full Text] [Related]
48. Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management.
Oda K; Hamanishi J; Matsuo K; Hasegawa K
Gynecol Oncol; 2018 Nov; 151(2):381-389. PubMed ID: 30217369
[TBL] [Abstract][Full Text] [Related]
49. MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance.
Gasparri ML; Besharat ZM; Farooqi AA; Khalid S; Taghavi K; Besharat RA; Sabato C; Papadia A; Panici PB; Mueller MD; Ferretti E
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2313-2318. PubMed ID: 30109500
[TBL] [Abstract][Full Text] [Related]
50. Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies.
Asati V; Bharti SK; Mahapatra DK; Asati V; Budhwani AK
Curr Pharm Des; 2016; 22(39):6039-6054. PubMed ID: 27296758
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
